4 completed, 1 not yet recruiting, 1 recruiting, 1 terminated. 8 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Completed 4, Not yet recruiting 1, Recruiting 1, Terminated 1, Unknown 1 |
Follow Lung Cancer, Small Cell: new trials by email Literature Review of Lung Cancer, Small Cell trials Research Report on Lung Cancer, Small Cell
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hypofractionated Radiotherapy Followed by Chemo-immunotherapy Induction Therapy Adebrelimab, EC/EP, SBRT - Lung Cancer, Small Cell, Limited-stage Small Cell Lung Cancer (LS-SCLC) | Phase 2 | Not yet recruiting | Tianjin Medical University Cancer Institute and Hospital | 30 | 2025-04-01 | 2025-04-25 |
| Efficacy and Safety of First-line Treatment for Extensive-stage Small Cell Lung Cancer Using a Combination Therapy of Trilaciclib, Envafolimab, Etoposide, and Carboplatin Chemotherapy （Etoposide and Carboplatin）, Immunotherapy （Envafolimab）, Trilaciclib - Lung Cancer, Small Cell | Phase 2 | Recruiting | Shanghai Chest Hospital | 52 | 2024-10-13 | 2024-11-21 |
| A Study to Investigate the Efficacy and Safety of Tislelizumab Combined With Sitravatinib as Maintenance Therapy for ES-SCLC Tislelizumab, Sitravatinib - Lung Cancer, Small Cell | Phase 2 | Unknown | Zhejiang Cancer Hospital | 21 | 2022-03-17 | 2023-09-26 |
| Trial of NanoPac Intratumoral Injection in Lung Cancer NanoPac (sterile nanoparticulate paclitaxel) Powder for Suspension - Lung Cancer, Nonsmall Cell, Lung Cancer | Phase 2 | Completed | NanOlogy, LLC | 18 | 2021-04-14 | 2025-05-23 |
| A Study to Evaluate Pazopanib in Comparison to Pemetrexed in Maintenance Setting in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) Population pazopanib, pemetrexed - Lung Cancer, Small Cell | Phase 2 | Terminated | GlaxoSmithKline | 20 | 2011-02-01 | 2014-10-27 |
| Study of Oral Topotecan With Bevacizumab for Recurrent Small Cell Lung Cancer Oral Hycamtin (topotecan) Capsules + IV Avastin (bevacizumab) - Recurrent Small-cell Lung Cancer (SCLC), Lung Cancer, Small Cell | Phase 2 | Completed | GlaxoSmithKline | 50 | 2008-07-01 | 2012-03-27 |
| First-line Treatment Of Subjects With Extensive Disease Small Cell Lung Cancer With Weekly Hycamtin And Paraplatin topotecan, carboplatin - Lung Cancer, Small Cell | Phase 2 | Completed | GlaxoSmithKline | 33 | 2005-06-01 | 2015-05-07 |
| The Study Of An Oral Drug Called A Radiation Sensitizer In Patients With Newly Diagnosed Small Cell Lung Cancer (SCLC) topotecan - Lung Cancer, Small Cell, Small Cell Lung Cancer | Phase 2 | Completed | GlaxoSmithKline | 60 | 2002-08-01 | 2017-05-31 |
Small Cell Lung Carcinoma (8) · Carcinoma, Non-Small-Cell Lung (2) · Lung Neoplasms (2)
Bronchial Neoplasms (8) · Carcinoma, Bronchogenic (8) · Lung Diseases (8) · Neoplasms (8) · Neoplasms by Site (8) · Respiratory Tract Diseases (8) · Respiratory Tract Neoplasms (8) · Thoracic Neoplasms (8) · Lung Neoplasms (6)
Topotecan (3) · Carboplatin (2) · Bevacizumab (1) · Capsules (1) · EC regimen (1) · Paclitaxel (1) · Pemetrexed (1) · Powders (1) · Suspensions (1) · envafolimab (1) · pazopanib (1) · sitravatinib (1) · tislelizumab (1) · trilaciclib (1)
GlaxoSmithKline (4) · NanOlogy, LLC (1) · Shanghai Chest Hospital (1) · Tianjin Medical University Cancer Institute and Hospital (1) · Zhejiang Cancer Hospital (1)
United States (5) · China (2) · Poland (1)